Researchers in the Departments of Urology and Radiology at UW-Madison are studying a promising new tool in the diagnosis and treatment of prostate cancer. Led by radiologists Steve Cho, MD, and Shane Wells, MD, and …
Research
Increased COX-1 Expression in Benign Prostate Epithelial Cells Triggered by Mitochondrial Dysfunction
In a new publication in American Journal of Clinical and Experimental Urology, Dr. William Ricke (UW O’Brien Center Director) and Dr. Don DeFranco (University of Pittsburgh P20 Center) and colleagues demonstrate that COX-1 and mitochondrial …
UW Urology ranked 7th in Urology Departments for NIH funding in FY 2021
The Blue Ridge Institute for Medical Research (BRIMR) has publicly released its NIH Funding to U.S. Medical Schools rankings for the 2021 federal fiscal year. Our department is ranked #7 in the nation for urology …
O’Brien Center researchers and colleagues implicate bisphenol-A and its replacements in the development and progression of LUTD
In a new publication in Biochemical Pharmacology, former Ricke Lab postdoc Dr. Jalissa Nguyen and researchers in Dr. William Ricke’s lab, in collaboration with colleagues at UCSF, the University of Iowa, the University of South …
Dr. Petra Popovics (Scientist I/K01 Scholar) in Dr. William Ricke’s laboratory and collaborators at University of Miami demonstrate the potential use for GHRH antagonists for clinical therapy of human cancers and other diseases
In a new publication in Peptides, Dr. Petra Popovics (Scientist I/K01 Scholar in Dr. William Ricke’s laboratory) and colleagues at the University of Miami, demonstrate the potential use of GHRH antagonists for clinical therapy of …
New publication by Hannah Miles (Pharmaceutical Sciences PhD student in the laboratories of Drs. William Ricke and Lingjun Li) and colleagues demonstrates a mechanistic link between aberrant intracellular citrate/acetyl coenzyme A flux and the development of an autistic-like phenotype in mice
In a new publication in Brain Communications, Hannah Miles (Pharmaceutical Sciences PhD candidate in the laboratories of Drs. William Ricke & Lingjun Li) and collaborators demonstrate a mechanistic link between aberrant intracellular citrate/acetyl coenzyme A …
UW Scientist Explores Novel Target for Treatment of LUTS
More than half of men over the age of 50 experience lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). While LUTS is a common, benign condition, it reduces the quality of life …
New research from Dr. William Ricke and collaborators demonstrates that metabolic syndrome leads to detrusor hypertrophy and may contribute to impaired bladder function
In a new publication in Urology, researchers at the UW O’Brien Center and UW Department of Urology demonstrate that metabolic syndrome leads to detrusor hypertrophy and may contribute to impaired bladder function, likely related to …
Dr. Will Ricke honored with the 2019 Society of Toxicology’s Kenneth P. DuBois Award
Dr. Will Ricke received the 2019 Society of Toxicology’s Kenneth P. DuBois Award. The award honors an outstanding Midwest toxicologist with a distinguished and longstanding career in toxicological research.
David Jarrard, MD, receives five-year renewal of NIH RO1 grant in the amount of $2.9 million
David Jarrard, MD, and Professor of Chemistry Lloyd Smith, received a five-year renewal of their NIH RO1 grant in the amount of $2.9 million. The title of the project is “Sequence-specific Hybridization Capture for Discovery of …